Author:
ÇAKMAK Reşit,ÇINAR Ercan,BAŞARAN Eyüp,BOĞA Mehmet
Reference29 articles.
1. [1] Yokeş, M. B., “Molecular genetics of Alzheimer's Disease”, Journal of Cellular and Molecular Medicine, 6, 73-97, 2007.
2. [2] Mesulam, M. M., Principles of behavioral and cognitive neurology. Oxford University Press, Oxford 2000.
3. [3] Lleo, A., Greenberg, S. M., Growdon, J. H., “Current pharmacotherapy for Alzheimer's disease”, Annual Review of Medicine, 57, 513-533, 2006.
4. [4] Flynn, B. L., Ranno, A. E., “Pharmacologic management of Alzheimer disease part II: Antioxidants, antihypertensives, and ergoloid derivatives”, Annals of Pharmacotherapy, 33, 188-197, 1999.
5. [5] Yaari, R., Corey-Bloom, J., “Alzheimer's disease”, Seminars in Neurology, 27, 32-41, 2007.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Histopathological, Antioxidant, and Enzyme Activity of Boronic Incorporated Catechin Compound: Screening of Bioactivity with Molecular Docking Studies;Russian Journal of Bioorganic Chemistry;2024-08
2. Experimental and theoretical studies on inhibition against tyrosinase activity and melanin biosynthesis by antioxidant ergothioneine;Biochemical and Biophysical Research Communications;2023-11
3. Tyrosinase Inhibitory Peptides from Enzyme Hydrolyzed Royal Jelly: Production, Separation, Identification and Docking Analysis;Foods;2023-06-01
4. Synthesis, antioxidant, and anticholinesterase activities of novel N‐arylsulfonyl hydrazones bearing sulfonate ester scaffold;Journal of the Chinese Chemical Society;2023-05-04
5. Novel different furoic acid‐linked axial silicon phthalocyanines: Design, syntheses, cholinesterases, tyrosinase inhibitory, and DNA damage studies;Applied Organometallic Chemistry;2023-02-12